Chesapeake Capital Corp IL purchased a new stake in Enovix Co. (NASDAQ:ENVX – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 10,531 shares of the company’s stock, valued at approximately $163,000.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Enovix by 1.3% in the first quarter. Vanguard Group Inc. now owns 13,093,710 shares of the company’s stock valued at $104,881,000 after purchasing an additional 164,717 shares in the last quarter. Electron Capital Partners LLC lifted its stake in shares of Enovix by 20.0% during the fourth quarter. Electron Capital Partners LLC now owns 3,239,296 shares of the company’s stock valued at $40,556,000 after buying an additional 540,399 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Enovix by 2,228.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,438,011 shares of the company’s stock valued at $11,518,000 after buying an additional 1,376,253 shares during the period. Masters Capital Management LLC lifted its stake in shares of Enovix by 3.8% during the first quarter. Masters Capital Management LLC now owns 1,350,000 shares of the company’s stock valued at $10,814,000 after buying an additional 50,000 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Enovix by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,089,959 shares of the company’s stock valued at $13,646,000 after buying an additional 55,157 shares during the period. Hedge funds and other institutional investors own 50.92% of the company’s stock.
Wall Street Analyst Weigh In
ENVX has been the topic of several recent analyst reports. B. Riley raised shares of Enovix to a “strong-buy” rating in a research note on Tuesday, June 25th. Benchmark initiated coverage on shares of Enovix in a research note on Monday, July 22nd. They set a “buy” rating and a $25.00 price objective on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research note on Thursday, August 1st. Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price target (down previously from $23.00) on shares of Enovix in a research report on Monday, August 5th. Finally, Craig Hallum upped their price target on shares of Enovix from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Enovix presently has a consensus rating of “Buy” and a consensus price target of $21.33.
Insider Transactions at Enovix
In related news, Director Gregory Reichow sold 7,500 shares of the firm’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $12.14, for a total transaction of $91,050.00. Following the completion of the sale, the director now directly owns 8,129 shares of the company’s stock, valued at approximately $98,686.06. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 17.30% of the company’s stock.
Enovix Price Performance
Enovix stock opened at $8.27 on Wednesday. Enovix Co. has a 52-week low of $5.70 and a 52-week high of $18.68. The firm has a fifty day moving average of $12.56 and a 200-day moving average of $10.56. The firm has a market capitalization of $1.41 billion, a P/E ratio of -6.17 and a beta of 1.99. The company has a quick ratio of 3.84, a current ratio of 3.98 and a debt-to-equity ratio of 0.97.
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Enovix had a negative net margin of 1,434.34% and a negative return on equity of 91.21%. The company had revenue of $3.77 million during the quarter, compared to analyst estimates of $3.85 million. As a group, analysts predict that Enovix Co. will post -1.21 EPS for the current year.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- What is a Secondary Public Offering? What Investors Need to Know
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Transportation Stocks Investing
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- What is MarketRankā¢? How to Use it
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.